OraSure Technologies to Participate at the 2008 UBS Global Life Sciences Conference

  
    
  
  
    
      OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. 
      Michels, President and Chief Executive Officer, will speak to the 
      investment community at the 2008 UBS Global Life Sciences Conference in 
      New York City at approximately 2:30pm Eastern Time, (11:30am Pacific 
      Time) on Tuesday, September 23, 2008. The conference will be 
      simultaneously webcast over the Internet.
    
    
      Interested investors can access the live audio webcast of the discussion 
      by going to OraSure Technologies’ web site, www.orasure.com, 
      and clicking on the Investor Information link. A replay of the audio 
      webcast will be available until, September 30, 2008, on OraSure 
      Technologies’ web site.
    
    
      About OraSure Technologies
    
    
      OraSure Technologies develops, manufactures and markets oral fluid 
      specimen collection devices using proprietary oral fluid technologies, 
      diagnostic products including immunoassays and other in vitro 
      diagnostic tests, and other medical devices. These products are sold in 
      the United States as well as internationally to various clinical 
      laboratories, hospitals, clinics, community-based organizations and 
      other public health organizations, distributors, government agencies, 
      physicians’ offices, and commercial and 
      industrial entities.
    
    
      OraSure Technologies is the leading supplier of oral-fluid collection 
      devices and assays to the life insurance industry and public health 
      markets for the detection of antibodies to HIV. In addition, the Company 
      supplies oral-fluid testing solutions for drugs of abuse testing. For 
      more information on the Company, please go to www.orasure.com.